Hung-Fun Lu

Title: The Innovations of Hung-Fun Lu in Pharmaceutical Development

Introduction

Hung-Fun Lu is an accomplished inventor based in Manchester, MO, recognized for his contributions to the field of pharmaceuticals. With a focus on developing innovative therapeutic solutions, Lu has made significant strides in the area of integrin receptor antagonism.

Latest Patents

Hung-Fun Lu holds one patent titled "Heteroarylalkanoic acids as integrin receptor antagonists." This patent describes a novel class of compounds represented by a specific formula, including pharmaceutically acceptable salts. The invention focuses on methods for selectively antagonizing the αβ and/or the αβ integrin receptors without significantly affecting the IIb/IIIa or αβ integrin pathways. This innovation has promising implications for therapeutic applications in various diseases.

Career Highlights

Throughout his career, Lu has been affiliated with Pharmacia Corporation, contributing to their mission of advancing pharmaceutical technology. His work emphasizes the importance of developing compounds that can effectively target specific receptors, enhancing treatment efficacy while minimizing side effects.

Collaborations

Lu has collaborated with esteemed colleagues such as Srinivasan Raj Nagarajan and Ish K Khanna. These collaborations reflect a dynamic work environment, fostering the exchange of ideas and collective problem-solving in the realm of pharmaceutical research and development.

Conclusion

Hung-Fun Lu's innovative work in the field of pharmaceuticals, particularly in the development of integrin receptor antagonists, showcases his dedication to advancing medical science. As he continues his career at Pharmacia Corporation, his contributions are expected to lead to further breakthroughs in effective treatments for patients. The importance of collaboration with fellow researchers cannot be understated, as it fuels continued innovation and progress in this vital field.